Drug Type Small molecule drug |
Synonyms NCCG, GBC-590, GCS 100 + [2] |
Target |
Action inhibitors |
Mechanism galectin-3 inhibitors(Galectin-3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Phase 2 | United States | 01 Mar 2015 | |
Non-diabetic Chronic Kidney Disease | Phase 2 | United States | 01 Mar 2015 | |
Chronic Kidney Diseases | Phase 2 | United States | 01 Jun 2013 | |
Diffuse large B-cell lymphoma recurrent | Phase 2 | United States | 01 Jul 2008 | |
Chronic Lymphocytic Leukemia | Phase 2 | United States | 01 Feb 2007 | |
Colorectal Cancer | Phase 2 | United States | - | |
Colorectal Cancer | Phase 2 | - | - | |
Pancreatic Cancer | Phase 2 | United States | - | |
Pancreatic Cancer | Phase 2 | - | - | |
Prostatic Cancer | Phase 2 | United States | - |
Phase 2 | 24 | bxckubtjps(byhswfivjo) = relfrqgmxp ufctqjsahq (nfeqakyhjz ) | - | 20 May 2009 |